Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Sales | 122,473 | 205,197 | 206,625 | 102,814 | 88,268 |
| Gross Profit | 122,473 | 205,197 | 206,625 | 102,814 | 88,268 |
| Operating Expenses | 164,112 | 168,459 | 118,297 | 78,200 | 57,427 |
| Operating Income | -41,639 | 36,738 | 88,328 | 24,614 | 30,841 |
| Other Income | 6,620 | 8,819 | 4,793 | 2,333 | 1,719 |
| Pre-tax Income | -35,019 | 45,557 | 93,121 | 26,947 | 32,560 |
| Income Tax | 1,149 | -826 | 21,165 | 9,237 | 10,894 |
| Net Income Continuous | -36,168 | 46,383 | 71,956 | 17,710 | 21,666 |
| Net Income | $-36,168 | $46,383 | $71,956 | $17,710 | $21,666 |
| EPS Basic Total Ops | -1.81 | 2.37 | 3.74 | 0.93 | 1.14 |
| EPS Basic Continuous Ops | -1.81 | 2.37 | 3.74 | 0.93 | 1.14 |
| EPS Diluted Total Ops | -1.81 | 2.21 | 3.48 | 0.91 | 1.13 |
| EPS Diluted Continuous Ops | -1.81 | 2.21 | 3.48 | 0.91 | 1.13 |
| EPS Diluted Before Non-Recurring Items | -0.89 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-37,691 | $35,660 | $90,011 | $27,453 | $34,013 |